Loading
Stroke / Cardiovascular Diseases / Cardiovascular Risk Factor · Observational Study
ClinicalTrials.gov · August 13, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record for an ongoing prospective observational cohort study of 800 patients with first-ever ischemic stroke in Central Norway, designed to track recurrent stroke, mortality, functional disability, and quality of life over 10 years. No results are posted in this registry entry; the study is active but not yet recruiting, and outcome data are not yet available.
Observational. Stroke, Cardiovascular Diseases, Cardiovascular Risk Factor, Brain Ischemia, Cerebrovascular Disorders, Nervous System Diseases, Central Nervous System Lymphom…; age from 18 Years; to 90 Years. Intervention: First time ischemic stroke. n = 800. 8 sites: Norway.
This is a registry record for an ongoing prospective observational cohort study of 800 patients with first-ever ischemic stroke in Central Norway, designed to track recurrent stroke, mortality, functional disability, and quality of life over 10 years. No results are posted in this registry entry; the study is active but not yet recruiting, and outcome data are not yet available.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Results from this cohort, when reported, may provide prognostic data and identify modifiable risk factors (physical activity, medication adherence for secondary prevention, blood pressure and cholesterol control, smoking cessation) relevant to stroke outcomes and quality of life. However, no clinical guidance can be drawn from this registry record until outcomes are published.
This is a clinical trial registry record documenting a planned observational cohort study with no results yet reported; it describes study design and objectives only.
As stated by the source record.
Quoted from the source exactly as published.
Results from this cohort, when reported, may provide prognostic data and identify modifiable risk factors (physical activity, medication adherence for secondary prevention, blood pressure and cholesterol control, smoking cessation) relevant to stroke outcomes and quality of life. However, no clinical guidance can be drawn from this registry record until outcomes are published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT03962127). This is a study registration, not published results. Lead sponsor: Norwegian University of Science and Technology. Recruitment status: ACTIVE_NOT_RECRUITING. Study type: OBSERVATIONAL. Enrollment: 800 participants (ACTUAL). Conditions: Stroke, Cardiovascular Diseases, Cardiovascular Risk Factor, Brain Ischemia, Cerebrovascular Disorders, Nervous System Diseases, Central Nervous System Lymphoma, Pathologic Processes, Vascular Diseases. Interventions: OTHER: no intervention. Primary outcome measures: The incidence of recurrent stroke after first ever ischemic stroke , 3 months; The incidence of recurrent stroke after first ever ischemic stroke , 1 year; The incidence of recurrent stroke after first ever ischemic stroke , 3 years; The incidence of recurrent stroke after first ever ischemic stroke , 5 years; The incidence of recurrent stroke after first ever ischemic stroke , 10 years; Mortality after first ischemic stroke , 3 months; Mortality after first ischemic stroke , 1 year; Mortality after first ischemic stroke , 3 years; Mortality after first ischemic stroke , 5 years; Mortality after first ischemic stroke , 10 years; Functional disability after stroke , 3 months after stroke; Functional disability after stroke , 1 year after stroke; Functional disability after stroke , 3 years after stroke; Functional disability after stroke , 5 years after stroke; Functional disability after stroke , 10 years after stroke; Health-related quality of life after stroke , 3 months after stroke; Health-related quality of life after stroke , 1 year after stroke; Health-related quality of life after stroke , 3 years after stroke; Health-related quality of life after stroke , 5 years after stroke; Health-related quality of life after stroke , 10 years after stroke. Brief summary: Annually 13000 Norwegians experience an ischemic stroke. The number of stroke is anticipated to increase with 50% within 2030 due to a growing number of elderly. Many of them will have severe function deficits and reduced quality of life. The investigators have established a cohort consisting of 800 patients with first time ischemic stroke treated at hospitals in Central Norway. The investigators want to study the incidence and prognostic markers for death, recurrent stroke and severe functional deficits during a period of 10 years after the initial ischemic stroke. The investigators want to focus on the impact of physical functioning, the level of physical activity and use of medication for secondary prevention on the incidence of death, recurrent stroke and severe functional deficits. The investigators are especially interested in the importance of fulfilling the treatment targets for blood pressure and cholesterol and the importance of smoking cessation in stroke survivors. Our objective is to improve todays stroke treatment and achieve a more efficient use of the health resources in order to increase survival after stroke maintaining a good physical and psychological function and quality of life.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.